Emotional awareness therapy for fibromyalgia pain in people with lupus
Tests a talk therapy for widespread pain in adults with lupus.
Plain-language title generated from the registry record
Registry title: Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
Key facts
- Where
- Salt Lake City, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07282392, who can take part
Where in United States
- University of UtahSalt Lake City, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Utah
- Trial code
- NCT07282392
- Record updated
- 29 December 2025
- Original description
The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are:Read full original descriptionShow less
Evaluating the Feasibility and Efficacy of Emotional Awareness and Expression Therapy (EAET) on Fibromyalgia Outcomes in Patients With Systemic Lupus Erythematosus (SLE).
The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are:
Is the psychotherapy treatment safe for lupus patients? Are lupus patients able to complete the treatment? Can the treatment help improve chronic pain and other symptoms in lupus patients?
Researchers will compare the treatment to a control (participants who will continue their medical treatment but will not receive psychotherapy for the time frame of the treatment) to see if the psychotherapy treatment works to relieve widespread pain and other lupus-related symptoms.
Participants will:
Fill out questionnaires before and after the treatment. Participate in 8 weekly treatment sessions, 2 hours per session, delivered via Zoom from their own home.
Keep a list of medications and monitor any changes in their medication regimen.
Inclusion: Adults of all genders, ages 18-65; A diagnosis of lupus and fibromyalgia or chronic widespread pain by a licensed rheumatologist; Be on a stable medication regimen.
Exclusion: Changes in medications in the past 3 months; Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications; Untreated alcohol or substance use disorder; Substantial cognitive impairment; Failure to complete the baseline assessments; Active suicidal ideation; Enrollment in another treatment study; Current involvement in health-related litigation or disability application; Inability to use a computer and/or smartphone; limited access to the internet; Inability to communicate in English.